Reports related to this article:
Project(s): View 6 related projects in PECWeb
Plant(s): View 5 related plants in PECWeb
Released September 17, 2024 | SUGAR LAND
en
Researched by Industrial Info Resources (Sugar Land, Texas)--Founded in 1990, DPR Construction (Redwood City, California) has become a leading U.S. construction firm, with 30 offices throughout the country joining a handful of international locations. The company has become a recognized expert in construction certified to the Leadership in Energy and Environmental Design (LEED) criteria, making DPR a popular choice for construction in the Pharmaceutical-Biotech Industry, where LEED-certified projects are most prevalent. While life science construction makes up the bulk of DPR's project activity, other projects, primarily in the Industrial Manufacturing Industry, feature in its working projects. Industrial Info is tracking projects valued at $9.8 billion that involve DPR.
With the majority of its projects in the pharma sector, the highest-value project in DPR's portfolio falls under this umbrella, geared toward the lucrative market of insulin injectables. Construction on Eli Lilly and Company's (NYSE:LLY) (Indianapolis, Indiana) grassroot plant kicked off in the Research Triangle Park area of North Carolina in 2020, where DPR is currently winding down Phase I of the project, drawing to a close construction of 12 buildings totaling 750,000 square feet and paving the way for the plant to begin production of Trulicity and Tirzepatide injectables, which are used in the treatment of type II diabetes.
A few months ago, with the completion of Phase I within its sights after years of work, Lilly authorized DPR to begin work on Phase II, which entails fitting out additional expansion buildings, adding another half a million square feet of building space. When DPR completes this phase, which is expected toward the end of next year, the facility will be able to manufacture approximately 300 million doses of diabetes drugs annually. Subscribers to Industrial Info's Pharma-Bio Global Market Intelligence (GMI) Project Database can learn more by viewing the reports on Phase I and Phase II.
Across the country in San Diego, California, Bristol-Myers Squibb Company (NYSE:BMY) (New York, New York) is employing DPR as a subcontractor on the construction of a LEED Gold-certified building. The 430,000-square-foot building will serve as a base for the research and development of novel biologics and therapeutics. Construction began earlier this year and is expected to be completed in 2026. Subscribers can learn more by viewing the project report.
But DPR is involved in much more than the medical field. In Rock Hill, South Carolina, DPR is on the cutting edge of high-tech devices as it renovates an existing, unoccupied building to house the corporate headquarters and manufacturing space of Pallidus Incorporated (Albany, New York), which manufactures silicon carbide wafers used for semiconductors in sectors such as electric vehicles, power transmissions, data centers and telecommunications. Having begun construction in the first half of last year, DPR is expected to complete the facility later this year. Subscribers to Industrial Info's Industrial Manufacturing Project Database can click here for more details on the project.
Further downstream in the tech world, DPR has bagged a few lucrative contracts with Facebook and Instagram parent Meta Platforms Incorporated (NASDAQ:META) (Menlo Park, California). One of the DPR's largest projects for Meta is expected to kick off next year. DPR will head up construction of two buildings totaling 715,000 square feet to support regional data operations from Graniteville, South Carolina, in the west of the state only 20 miles from Augusta, Georgia. The South Carolina facility will be on the cutting edge of today's technologies, optimized for artificial intelligence workloads. The project is expected to be completed in 2027. Subscribers can learn more by viewing the project report.
With several other companies lined up for projects, DPR has data center projects valued at more than $3.5 billion underway or planned for the future. Subscribers can click here for a full listing of DPR's active data center projects.
DPR also is involved with the U.S. military via The Boeing Company (NYSE:BA) (Arlington, Virginia), for whom DPR is expanding a rockets and satellites plant in Huntsville, Alabama. Late last year, DPR began construction on a 35,000-square-foot building that will house equipment systems to increase the facility's production of the PAC-3 seeker missile by 30% for the U.S. military and its allies. DPR is expected to complete the project in early 2025. Subscribers can click here to learn more about the project.
Subscribers to Industrial Info's GMI Database can click here to view reports for all of the projects discussed in this article and click here for the related plant profiles.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 trillion (USD).
With the majority of its projects in the pharma sector, the highest-value project in DPR's portfolio falls under this umbrella, geared toward the lucrative market of insulin injectables. Construction on Eli Lilly and Company's (NYSE:LLY) (Indianapolis, Indiana) grassroot plant kicked off in the Research Triangle Park area of North Carolina in 2020, where DPR is currently winding down Phase I of the project, drawing to a close construction of 12 buildings totaling 750,000 square feet and paving the way for the plant to begin production of Trulicity and Tirzepatide injectables, which are used in the treatment of type II diabetes.
A few months ago, with the completion of Phase I within its sights after years of work, Lilly authorized DPR to begin work on Phase II, which entails fitting out additional expansion buildings, adding another half a million square feet of building space. When DPR completes this phase, which is expected toward the end of next year, the facility will be able to manufacture approximately 300 million doses of diabetes drugs annually. Subscribers to Industrial Info's Pharma-Bio Global Market Intelligence (GMI) Project Database can learn more by viewing the reports on Phase I and Phase II.
Across the country in San Diego, California, Bristol-Myers Squibb Company (NYSE:BMY) (New York, New York) is employing DPR as a subcontractor on the construction of a LEED Gold-certified building. The 430,000-square-foot building will serve as a base for the research and development of novel biologics and therapeutics. Construction began earlier this year and is expected to be completed in 2026. Subscribers can learn more by viewing the project report.
But DPR is involved in much more than the medical field. In Rock Hill, South Carolina, DPR is on the cutting edge of high-tech devices as it renovates an existing, unoccupied building to house the corporate headquarters and manufacturing space of Pallidus Incorporated (Albany, New York), which manufactures silicon carbide wafers used for semiconductors in sectors such as electric vehicles, power transmissions, data centers and telecommunications. Having begun construction in the first half of last year, DPR is expected to complete the facility later this year. Subscribers to Industrial Info's Industrial Manufacturing Project Database can click here for more details on the project.
Further downstream in the tech world, DPR has bagged a few lucrative contracts with Facebook and Instagram parent Meta Platforms Incorporated (NASDAQ:META) (Menlo Park, California). One of the DPR's largest projects for Meta is expected to kick off next year. DPR will head up construction of two buildings totaling 715,000 square feet to support regional data operations from Graniteville, South Carolina, in the west of the state only 20 miles from Augusta, Georgia. The South Carolina facility will be on the cutting edge of today's technologies, optimized for artificial intelligence workloads. The project is expected to be completed in 2027. Subscribers can learn more by viewing the project report.
With several other companies lined up for projects, DPR has data center projects valued at more than $3.5 billion underway or planned for the future. Subscribers can click here for a full listing of DPR's active data center projects.
DPR also is involved with the U.S. military via The Boeing Company (NYSE:BA) (Arlington, Virginia), for whom DPR is expanding a rockets and satellites plant in Huntsville, Alabama. Late last year, DPR began construction on a 35,000-square-foot building that will house equipment systems to increase the facility's production of the PAC-3 seeker missile by 30% for the U.S. military and its allies. DPR is expected to complete the project in early 2025. Subscribers can click here to learn more about the project.
Subscribers to Industrial Info's GMI Database can click here to view reports for all of the projects discussed in this article and click here for the related plant profiles.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 trillion (USD).
